Found: 44
Select item for more details and to access through your institution.
The Cappuzzo/Finocchiaro/Trisolini el al Article Reviewed.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 8, p. 1003
- By:
- Publication type:
- Article
Anti-Angiogenesis Therapy in the Treatment of Non-Small Cell Lung Cancer: The Role of Monoclonal Antibodies and Multitargeted Tyrosine Kinase Inhibitors.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 23
- By:
- Publication type:
- Article
Targeted therapy of advanced non-small cell lung cancer: the role of bevacizumab.
- Published in:
- Biologics: Targets & Therapy, 2007, v. 1, n. 3, p. 185
- By:
- Publication type:
- Article
Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair–Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 3, p. 187, doi. 10.1016/j.cllc.2021.01.001
- By:
- Publication type:
- Article
A Phase II Study of Telisotuzumab Vedotin in Patients With c–MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753).
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 3, p. 170, doi. 10.1016/j.cllc.2020.09.013
- By:
- Publication type:
- Article
Randomized Study of Maintenance Pemetrexed Versus Observation for Treatment of Malignant Pleural Mesothelioma: CALGB 30901.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Real-World Outcomes for Advanced Non-Small Cell Lung Cancer Patients Treated With a PD-L1 Inhibitor Beyond Progression.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase Ib Study of Bavituximab With Carboplatin and Pemetrexed in Chemotherapy-Naive Advanced Nonsquamous Non-Small-Cell Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pemetrexed With Platinum Combination as a Backbone for Targeted Therapy in Non-Small-Cell Lung Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Treatment of Surgically Resectable Non–Small-Cell Lung Cancer in Elderly Patients.
- Published in:
- Clinical Lung Cancer, 2009, v. 10, n. 6, p. 405, doi. 10.3816/CLC.2009.n.076
- By:
- Publication type:
- Article
Identification of osimertinib-resistant EGFR L792 mutations by cfDNA sequencing: oncogenic activity assessment and prevalence in large cfDNA cohort.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0148-7
- By:
- Publication type:
- Article
Neoadjuvant and Adjuvant Systemic Therapy for Early-Stage Non-small-Cell Lung Cancer.
- Published in:
- Drugs, 2022, v. 82, n. 8, p. 855, doi. 10.1007/s40265-022-01721-3
- By:
- Publication type:
- Article
Current management of RET rearranged non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920928634
- By:
- Publication type:
- Article
ACR Appropriateness Criteria® Nonsurgical Treatment for Locally Advanced Non-Small-Cell Lung Cancer: Good Performance Status/Definitive Intent.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 8, p. 706
- By:
- Publication type:
- Article
Potentially functional variants of ERAP1, PSMF1 and NCF2 in the MHC-I-related pathway predict non-small cell lung cancer survival.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 10, p. 2819, doi. 10.1007/s00262-021-02877-9
- By:
- Publication type:
- Article
Using a Clinically Interpretable End Point Composed of Multiple Outcomes to Evaluate Totality of Treatment Effect in Comparative Oncology Studies.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 6, p. e2319055, doi. 10.1001/jamanetworkopen.2023.19055
- By:
- Publication type:
- Article
The Role of Induction Therapy for Resectable Non-Small Cell Lung Cancer.
- Published in:
- Drugs, 2007, v. 67, n. 3, p. 321, doi. 10.2165/00003495-200767030-00001
- By:
- Publication type:
- Article
Novel agents in development for advanced non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2014, v. 6, n. 5, p. 240, doi. 10.1177/1758834014532510
- By:
- Publication type:
- Article
The Use of EGFR Tyrosine Kinase Inhibitors in EGFR Wild-Type Non-Small-Cell Lung Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Targeted Therapies for Locally Advanced or Metastatic Squamous Cell Carcinoma of the Lung.
- Published in:
- Current Treatment Options in Oncology, 2013, v. 14, n. 4, p. 568, doi. 10.1007/s11864-013-0256-2
- By:
- Publication type:
- Article
Functional variants in DCAF4 associated with lung cancer risk in European populations.
- Published in:
- Carcinogenesis, 2017, v. 38, n. 5, p. 541, doi. 10.1093/carcin/bgx033
- By:
- Publication type:
- Article
Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane) on three treatment schedules in patients with solid tumors.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Prognostic Factors in Limited-Stage Small Cell Lung Cancer: A Secondary Analysis of CALGB 30610–RTOG 0538.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 10, p. e2440673, doi. 10.1001/jamanetworkopen.2024.40673
- By:
- Publication type:
- Article
Novel genetic variants in KIF16B and NEDD4L in the endosome‐related genes are associated with nonsmall cell lung cancer survival.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 2, p. 392, doi. 10.1002/ijc.32739
- By:
- Publication type:
- Article
Genetic variant of IRAK2 in the toll‐like receptor signaling pathway and survival of non‐small cell lung cancer.
- Published in:
- International Journal of Cancer, 2018, v. 143, n. 10, p. 2400, doi. 10.1002/ijc.31660
- By:
- Publication type:
- Article
Treatment of KRAS-Mutant Non-Small Cell Lung Cancer: The End of the Beginning for Targeted Therapies.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The dysfibrinogenaemias.
- Published in:
- British Journal of Haematology, 2001, v. 114, n. 2, p. 249, doi. 10.1046/j.1365-2141.2001.02892.x
- By:
- Publication type:
- Article
Expanding Beyond Maximum Grade: Chemotherapy Toxicity over Time by Age and Performance Status in Advanced Non‐Small Cell Lung Cancer in CALGB 9730 (Alliance A151729).
- Published in:
- Oncologist, 2021, v. 26, n. 3, p. e435, doi. 10.1002/onco.13527
- By:
- Publication type:
- Article
Current Treatments for Surgically Resectable, Limited-Stage, and Extensive-Stage Small Cell Lung Cancer.
- Published in:
- Oncologist, 2017, v. 22, n. 12, p. 1510, doi. 10.1634/theoncologist.2017-0204
- By:
- Publication type:
- Article
Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials.
- Published in:
- Oncologist, 2017, v. 22, n. 2, p. 189, doi. 10.1634/theoncologist.2016-0121
- By:
- Publication type:
- Article
Randomized Phase II Study of Carboplatin With Weekly or Every-3-Week Nanoparticle Albumin-Bound Paclitaxel (Abraxane) in Patients With Extensive-Stage Small Cell Lung Cancer.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Randomized Phase II Study of Carboplatin With Weekly or Every-3-Week Nanoparticle Albumin-Bound Paclitaxel (Abraxane) in Patients With Extensive-Stage Small Cell Lung Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 2, p. 105, doi. 10.1634/theoncologist.2014-0327
- By:
- Publication type:
- Article
Second-Line Therapy for Advanced NSCLC.
- Published in:
- Oncologist, 2013, v. 18, n. 8, p. 947, doi. 10.1634/theoncologist.2013-0096
- By:
- Publication type:
- Article
Abstract 9 -- Targeted Therapies and Molecular Testing for Advanced Disease Non-Small Cell Lung Cancer.
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Novel Approaches of Chemoradiotherapy in Unresectable Stage IIIA and Stage IIIB Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2012, v. 17, n. 5, p. 682, doi. 10.1634/theoncologist.2012-0020
- By:
- Publication type:
- Article
Limited-Stage Small Cell Lung Cancer: Current Chemoradiotherapy Treatment Paradigms.
- Published in:
- Oncologist, 2010, v. 15, n. 2, p. 187, doi. 10.1634/theoncologist.2009-0298
- By:
- Publication type:
- Article
Gefitinib in Advanced Non-Small Cell Lung Cancer: Does It Deserve a Second Chance?
- Published in:
- Oncologist, 2008, v. 13, n. 9, p. 933, doi. 10.1634/theoncologist.2008-0019
- By:
- Publication type:
- Article
Considerations for Second-Line Therapy of Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2008, v. 13, p. 28, doi. 10.1634/theoncologist.13-S1-28
- By:
- Publication type:
- Article
Considerations for Second-Line Therapy of Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2008, v. 13, p. 28, doi. 10.1634/theoncologist.13-S1-28
- By:
- Publication type:
- Article
JASPER: Phase 2 trial of first‐line niraparib plus pembrolizumab in patients with advanced non–small cell lung cancer.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 65, doi. 10.1002/cncr.33885
- By:
- Publication type:
- Article
Validation of Interobserver Agreement in Lung Cancer Assessment: Hematoxylin-Eosin Diagnostic Reproducibility for Non-Small Cell Lung Cancer: The 2004 World Health Organization Classification and Therapeutically Relevant Subsets.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2013, v. 137, n. 1, p. 32, doi. 10.5858/arpa.2012-0033-OA
- By:
- Publication type:
- Article
The Association Between Medicare Low-Income Subsidy and Anticancer Treatment Uptake in Advanced Lung Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Sex-Based Disparities Among Cancer Clinical Trial Participants.
- Published in:
- 2020
- By:
- Publication type:
- Letter